申请人:YAMASA CORPORATION
公开号:EP0811624A1
公开(公告)日:1997-12-10
Purine or triazolopurine compounds represented by formula (I) or (II):
wherein R1 and R4 represent each hydrogen, halogeno, hydroxy, mercapto, or amino; R2 represents alkyl or aryl; and R3 and R5 represent each hydrogen, alkyl, or aryl; and pharmaceutical compositions comprising these compounds as an active ingredient in particular, xanthine oxidase inhibitors, remedies for hyperuricemia, or remedies or preventive agents for gout.
由式(I)或(II)代表的嘌呤或三唑嘌呤化合物:
其中 R1 和 R4 分别代表氢、卤素、羟基、巯基或氨基;R2 代表烷基或芳基;R3 和 R5 分别代表氢、烷基或芳基;以及包含这些化合物作为活性成分的药物组合物,特别是黄嘌呤氧化酶抑制剂、高尿酸血症治疗剂或痛风治疗剂或预防剂。